IQWiG: Tafinlar/Mekinist Benefit 'Considerable' In Men With Melanoma, But Still Better In Women

Germany's HTA body IQWiG has declared that there is "an indication of a considerable added benefit for men" of the combination of Novartis' Tafinlar and Mekinist (dabrafenib and trametinib).